UNSPSC 51151530: Telenzepine

This classification denotes an antimuscarinic agent with the molecular formula C19H22N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0990EG3K10, chemically known as 4,9-dihydro-3-methyl-4-((4-methyl-1-piperazinyl)acetyl)-10h-thieno(3,4-b)(1,5)benzodiazepin-10-one but generally known as telenzepine, which bears US NIH Compound Identifier 5387. European Medicines Agency schedules Telenzepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10871MIG.

UNSPSC 51151530 Telenzepine, a Commodity code, shows minimal alignment between the code's nominal scope and recent state and local procurement activity. The code nominally describes a specific pharmaceutical compound, yet the recent opportunities tagged to it procure naloxone, safe drug deactivation systems, and pharmacy benefit management services — products and services unrelated to telenzepine itself. State and local buyers using this code appear to be health and human services agencies, including county health departments and state HHS commissions, though the limited recent activity and the mismatch between the code designation and actual procurement content suggest either cataloging inconsistency or a narrow, specialized market with infrequent solicitation.

Geographic activity is limited to Florida and Texas based on recent postings. Seminole County, Florida issued IFB 60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, requiring quarterly deliveries and electronic bid submission through the county's e-procurement portal; the contract carries a two-year initial term with a one-year renewal option and is potentially FEMA-funded. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs operating outside traditional pharmacy benefit manager arrangements. The scarcity of recent opportunities and the clear mismatch between code designation and procurement substance suggest this code is rarely used for state and local procurements; firms pursuing activity in pharmaceutical supply or pharmacy benefit management should verify actual commodity coding in RFPs before relying on this UNSPSC designation.